United States Federal Circuit
Galderma Laboratories v. Tolmar, 13-1034
In a patent infringement action, the district court's judgment that plaintiffs' patent claims related to a topical acne medication are not invalid, is reversed and remanded, where the district court erred in finding the claims of the asserted patents not invalid as obvious.
Appellate Information
- Decided 12/11/2013
- Published 12/11/2013
Judges
- PROST
Court
- United States Federal Circuit